DiNardo, Courtney D.
The University of Texas MD Anderson Cancer Center,
United States
2025 Rank: 4,664
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 96 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4,664 | 4,066 |
| Total Cites | 5,804 | 6,831 |
| H-index | 32 | 35 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 62 | 62 |
| Total Cites to Single+First Authored Papers | 1,307 | 1,467 |
| Number of Single+First+Last Authored Papers | 115 | 115 |
| Total Cites to Single+First+Last Authored Papers | 1,721 | 1,954 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,805 | 3,061 |
| Ratio of Total Citations to Distinct Citing Papers | 2.07 | 2.23 |
| Self-Citation Percentage |
15.03%
|
|
DiNardo, Courtney D.
The University of Texas MD Anderson Cancer Center,
United States
2024 Rank: 7,962
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 187 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7,962 | 7,122 |
| Total Cites | 5,424 | 6,521 |
| H-index | 31 | 35 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 1,349 | 1,554 |
| Number of Single+First+Last Authored Papers | 102 | 102 |
| Total Cites to Single+First+Last Authored Papers | 1,675 | 1,922 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,459 | 2,702 |
| Ratio of Total Citations to Distinct Citing Papers | 2.21 | 2.41 |
| Self-Citation Percentage |
16.82%
|
|
DiNardo, Courtney D.
The University of Texas MD Anderson Cancer Center,
United States
2023 Rank: 8,831
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 222 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8,831 | 6,396 |
| Total Cites | 3,750 | 4,587 |
| H-index | 28 | 30 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 4 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 1,135 | 1,374 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 1,334 | 1,605 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,825 | 2,008 |
| Ratio of Total Citations to Distinct Citing Papers | 2.05 | 2.28 |
| Self-Citation Percentage |
18.25%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 260 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8,763 | 6,462 |
| Total Cites | 3,333 | 4,108 |
| H-index | 27 | 31 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 3 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1,135 | 1,377 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 1,313 | 1,584 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,682 | 1,856 |
| Ratio of Total Citations to Distinct Citing Papers | 1.98 | 2.21 |
| Self-Citation Percentage |
18.87%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 378 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14,774 | 10,693 |
| Total Cites | 3,992 | 4,906 |
| H-index | 29 | 34 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 3 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1,387 | 1,679 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 1,557 | 1,879 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,153 | 2,374 |
| Ratio of Total Citations to Distinct Citing Papers | 1.85 | 2.07 |
| Self-Citation Percentage |
18.63%
|
|
DiNardo, Courtney D.
University of Texas MD Anderson Cancer Center,
2020 Rank: 23,946
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 557 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23,946 | 23,187 |
| Total Cites | 2,078 | 2,475 |
| H-index | 21 | 22 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 659 | 785 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 735 | 865 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,265 | 1,436 |
| Ratio of Total Citations to Distinct Citing Papers | 1.64 | 1.72 |
| Self-Citation Percentage |
16.04%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.